1. Short title This Act may be cited as the Safer Prescribing of Controlled Substances Act . 2. Continuing education requirements for certain practitioners prescribing controlled substances Section 303 of the Controlled Substances Act ( 21 U.S.C. 823 ) is amended— (1) in subsection (f), in the matter preceding paragraph (1), by striking The Attorney General shall register and inserting Subject to subsection (j), the Attorney General shall register ; (2) by redesignating subsection (j) as subsection (k); and (3) by inserting after subsection (i) the following: (j) (1) In this subsection, the term covered practitioner means a practitioner that is not a hospital, pharmacy, or veterinarian. (2) As a condition of granting or renewing the registration of a covered practitioner under this part to dispense, or conduct research with, controlled substances in schedule II, III, IV, or V, the Attorney General shall require the covered practitioner to complete training (through classroom situations, seminars at professional society meetings, electronic communications, or otherwise) that the Secretary of Health and Human Services determines meets the requirements under paragraph (3). (3) The training provided for purposes of paragraph (2) shall, at a minimum, expose covered practitioners to— (A) best practices for pain management, including alternatives to prescribing controlled substances and other alternative therapies to decrease the use of opioids; (B) responsible prescribing of pain medications, as described in the Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain; (C) methods for diagnosing, treating, and managing a substance use disorder, including the use of medications approved by the Food and Drug Administration and evidence-based nonpharmacological therapies; (D) linking patients to evidence-based treatment for substance use disorders